Bioventures 2014 L.P. Mpm Sells 21,623 Shares of Entrada Therapeutics (NASDAQ:TRDA) StockMarket Beat·10 hours agoTRDA-8.14%BLK-0.29%
Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) Major Shareholder Sells 14,569 Shares of StockMarket Beat·10 hours agoTRDA-8.14%
MPM BioVentures 2018 reports Entrada Therapeutics common stock disposal worth $471,391.64PUBT·11 hours agoTRDA-8.14%
Entrada Therapeutics (NASDAQ:TRDA) Major Shareholder Ventures L.P. 5Am Sells 10,494 SharesMarket Beat·Aug 10 at 08:07 PMTRDA-8.14%
5AM Ventures V reports Entrada Therapeutics share disposal worth $431,620PUBT·Aug 10 at 06:53 PMTRDA-8.14%
Entrada Therapeutics publishes corporate presentation on genetic medicines pipeline for neuromuscular and inherited retinal diseasesPUBT·Aug 5 at 07:19 AMTRDA-8.14%VRTX-1.01%
Entrada Therapeutics, Inc. 2026: Revenue $898K, EPS ($1.01) — 10-Q SummaryTradingView·Aug 5 at 06:21 AMTRDA-8.14%VRTX-1.01%
Entrada Therapeutics | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 898 KEarnings Watch·Aug 5 at 06:06 AMTRDA-8.14%
Entrada Therapeutics director, 10% owner Kush Parmar disposes of $807,529 in common sharesPUBT·Aug 3 at 04:27 PMTRDA-8.14%
Entrada Therapeutics (NASDAQ:TRDA) Trading 1.1% Higher - Still a Buy?Market Beat·Jul 10 at 12:00 AMTRDA-8.14%IVZ+0.79%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Jun 5 at 04:06 PMTRDA-8.14%MBIO+1.45%
